ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements with these filters
Cian Healthcare intimated that its board will meet on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results.
Cian Healthcare granted 2,00,000 employee stock options at Rs 15 each on 4 November 2026. Options vest after one year, exercisable for five years thereafter.
Cian Healthcare disposed of its Dr. Smiths Biotech subsidiary under an NCLT-approved resolution plan. Its equity was cancelled with nil consideration receivable.
Cian Healthcare's subsidiary Dr. Smiths Biotech ceased to be a subsidiary after NCLT approved Ananta Medicare's resolution plan. Equity was extinguished with no consideration received.
Cian Healthcare filed its quarterly shareholding pattern. The company disclosed it is working to restore public shareholding levels following an NCLT-approved resolution plan.
Cian Healthcare Limited has appointed M/s. Rasool Singhal & Co. as the new Statutory Auditor for a term of 60 months.
Cian Healthcare Ltd held its 23rd AGM on September 29, 2026, approving financial statements, director re-appointment, auditor appointment, and the 2026 Employee Stock Option Scheme.
Cian Healthcare Limited has filed its Annual Report for the financial year ended March 31, 2026, and the Notice of its 23rd Annual General Meeting.
Cian Healthcare has instituted an Employee Stock Option Scheme (ESOS 2026), covering up to 10 million shares. No grants have been issued yet under this plan.
Cian Healthcare Limited appointed M/s Rasool Singhal & Co. as Statutory Auditor and M/s N D M & Company as Internal Auditor effective September 2, 2026.
Cian Healthcare appointed new auditors and approved the 2026 Employee Stock Option Scheme. The board also scheduled the 23rd Annual General Meeting for September 29, 2026.
Cian Healthcare Limited announced the resignation of its statutory auditor, M/s. S S R C A & Co., effective August 27, 2026, due to professional commitments.
Cian Healthcare announced the approval of nine resolutions via postal ballot. These include related party transactions, borrowing limit enhancements, and executive appointments approved by requisite majority.
Cian Healthcare Limited confirmed it is not classified as a Large Corporate as of March 31, 2026, under SEBI's framework for debt security issuance. The company reported outstanding borrowings of ₹13.55 Crore. Consequently, the mandatory debt-market borrowing requirements and associated disclosure compliances for large entities do not apply to the company for the upcoming financial year.